Company Team Search Site Map Careers Privacy Statement
:: Home
:: About Us
:: R&D
:: Products
:: Services
:: Infrastucture
:: Contact us
Virchow Products
Site Map
 

Home  

About Us
 

 

Group History

 

Mission

 

Company History
  Strategic Alliance

Research and Development  
 

 

Overview

 

R&D Vision

 

Pipeline
  Clinical Trials
  Doctral Program
 
Products  
Services  
 

 

Patient Assistance

 

Medical Proffessionals
 
Infrastructure  
 

 

Manufacturing Infrastructure

 

Regulatory Infrastructure

 

Marketing Infrastructure
 
Company  
Team  
Search  
Site Map  
Careers  
Privacy Statement  
     
 
News & Events

Virchow Biotech is filing for U.S.Food and Drug administration’s (FDA) approval for its in house developed advanced wound care products.

Virchow Biotech received Drug control’s (DCGI) approval for conducting clinical trials on periogen, an indigenously developed recombinant therapeutic product for periodontal diseases

Virchow Biotech and Ranbaxy signed an MOU to market Virchow’s indigenously developed recombinant therapeutic protein for osteoporosis treatment. We are the first in the world to launch this biogeneric product